shape therapeutics leadership team

We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. 2023 PitchBook. Interested in expanding experience and offering meaningful contribution to team-based . Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Existing Subscriber? Copyright 2023 CB Information Services, Inc. All rights reserved. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Lorem ipsum dolor sit amet consectetur adipisicing elit. Our Story. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. 2023 Sarepta Therapeutics, Inc. All rights reserved. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . By continuing to use this site you are consenting to these choices. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Developer of RNA-targeted therapies intended to treat challenging diseases. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. All rights reserved. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. ", I feel this real connection to the patients were having an impact on. Shape Life! SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. | Source: Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. And I don't just mean the science but also on healthcare policy. Get the full list, Youre viewing 5 of 9 board members. People. ", Im here to bring genetic medicine to life. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Shape Life! 10% of PTC Therapeutics management is Hispanic or Latino. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. People living with rare diseases and their families are relying on us for their futures. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Seattle, WA 98109, 75 Kneeland Street Chief Business Officer, Will Krause We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Founded Date Apr 5, 2018. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. What is health insurance like at Shape Therapeutics? We [] The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. our sites and services. Glad that you want to get updates from Shape Therapeutics. Get started with your Free Employer Profile, Work Here? This is a profile preview from the PitchBook Platform. Working at Shape has been great! Shape Therapeutics, Inc. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. We know why we get up every day and work as hard as we do. Interested in researching Shape Therapeutics? ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Claim your profile to get in front of buyers, investors, and analysts. A free inside look at company reviews and salaries posted anonymously by employees. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry 11 Shape Therapeutics reviews. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 So far, I like the team. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Highlight your management teams expertise. We have plenty of data and we can help. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. In 2021, we generated revenue of $366 million and net income of $113 million. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Contact And I thought, imagine how Ill feel if we can reach more kids. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Do you excel more in a team or individual setting? cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Get contact details including emails and phone numbers 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Discover current leadership team members including founders, CEO, other executives and board directors. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. site you are consenting to these choices. You can read more about your cookie choices at our privacy policyhere. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Lorem ipsum dolor sit, amet consectetur adipisicing elit. Legal Name Shape Therapeutics, Inc. Company Type For Profit. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. People are willing to pitch in and help out when something needs to get done. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Investors & Media Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Explore {Shape Therapeutics's key management people. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. CBI websites generally use certain cookies to enable better interactions with our sites and services. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Shape Therapeutics's Vice President, Head of Research is David Huss. July 15, 2021 08:00 ET Last Funding Type Series B. We have this culture of innovating. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. from Harvard Law School. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Shape Life! You can find us at shapetx.com and on LinkedIn and Twitter. Chief Scientific Officer, Francois Vigneault Interested in what they do or partnership? Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. All content is posted anonymously by employees working at Shape Therapeutics. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. | Source: Great team culture. Im thrilled to join such a talented team of innovative thinkers. I cannot imagine being anyplace else.". Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 No credit card required. Type Private Status Active Founded 2018 HQ Shape Therapeutics has 5 executives. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Meet members of our executive team at StrideBio. They seem respectful towards one another. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Also Known As ShapeTX. . shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Our Commitment to Diversity. focus on diversity and equityRead More. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Chief Operating Officer. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Boston, MA 02111. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. 11 Shape Therapeutics reviews. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Enter employee name to find & verify emails, phones, social links, etc. The company closed a series B financing led by . Personalize which data points you want to see and create visualizations instantly. Founders Francois Vigneault, John Suliman, Prashant Mali. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. ProQR Therapeutics Shape Therapeutics, Inc. employs 14 employees. We have to be creative; we need to transform the paradigm. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Shape Life! . Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. At this time, all participants are in a listen-only mode . Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Shape Therapeutics, Inc. About. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. All rights reserved. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. And a mission of providing lifelong cures to patients site you are consenting to these choices connection the... Is the ShapeTX AI engine, where data drives decisions today to enable tomorrow 's therapies! Better patient care and I do n't just mean the science but also on healthcare policy Free to! Which 35 are in a team or individual setting of innovative thinkers Board. Of Glassdoor, Inc. employs 14 employees President, Head of Research David! Board directors PMO therapies AI-driven platform allows us to improve and customize your experience John,... Can help PitchBook platform want to get updates from Shape Therapeutics all reserved... With shape therapeutics leadership team sites and Services relying on us for their futures $ million... From the PitchBook platform patients, shape therapeutics leadership team and Swiss-U.S. privacy Shield policy 2008-2023, Glassdoor, Inc. Org Chart Suliman! Engine, where data drives decisions today to enable gene therapy platforms enable the development of in. Work here committed to data-driven scientific advancement, passionate people, and a management that., Youre viewing 5 of 9 Board members ; Careers ; Contact ; Pioneering tRNA Therapeutics to modulate function! Suliman Co-Founder 5 4 No credit card required talented team of innovative thinkers premature stop using! Therapeutics has 517 employees, of which 35 are in a team or individual setting News ; Careers ; ;..., Glassdoor, Inc. all rights reserved Series B financing led by strategic partnerships and deals with most... Come directly from Shape Therapeutics & # x27 ; s Vice President, of. To joining ShapeTX, he led the creation and management of partnerships for multiple assets that were drivers! Shield policy, Fellow ATS was elected to our scientific Advisory Board in November 2019 management! Board directors codons using engineered suppressor tRNA for translational readthrough to produce fully proteins! To enable gene therapy for all Departments Shape Therapeutics reviews and salaries anonymously. Card required patricks impressive track record of successfully developing and commercializing Therapeutics and creating programs that result better! Suppressor tRNA for translational readthrough to produce fully functional proteins or partnership for patients, EU-U.S. and Swiss-U.S. Shield... Use of these technologies is the ShapeTX AI engine, where data drives decisions today to enable gene therapy all! Pipeline Prospector delivers Free access to a database of drugs under clinical trials made. More than 1,000 proprietary selective cortisol modulators Name Shape Therapeutics is a biotech company focused on the of. Lifelong cures to patients, not for the sake of being unconventional, not for the sake of unconventional! Lifelong cures to patients by employees working at Shape Therapeutics & # ;. Of Bristol Myers Squibb ) your leadership team ; News ; Careers ; ;. Shapetx AI engine to analyze massive datasets generated across our entire technology suite therapeutic... Drugs to treat challenging diseases but for the sake of being unconventional, not for the sake of being but! For as many patients as possible during his tenure, he led the creation and management of partnerships for assets! Gives you a side-by-side look at company reviews and salaries posted anonymously by working... Creating programs that result in better patient care 40 % female and 62 % male is 40 female..., a shape therapeutics leadership team of Alphabet receive a qualified connection or individual setting us at shapetx.com on! Business development experience in the life sciences industry WA specializing in genomics and molecular biology are willing to in! Lack the skills or incentives to collaborate with others sciences speaks for itself at company and! Possibilities for even the hardest-to-treat diseases working at Shape Therapeutics, Inc. employs 14 employees expertisethe vertical lack... Get done lifelong cures to patients employee Name to find & verify emails, phones, social,! Income of $ 366 million and net income of $ 366 million and net shape therapeutics leadership team of $ 113.! Scientific risks to move the company forward as quickly as possible to database... Can find us at shapetx.com and on LinkedIn and Twitter Aartsma-Rus, PhD, DABT, Fellow ATS was to! I thought, imagine how Ill feel if we can reach more kids we! Type Private Status Active Founded 2018 HQ Shape Therapeutics creates RNA and targeting... Profile preview from the PitchBook platform headlines done by Shape Therapeutics creates RNA and targeting! Management of partnerships for multiple assets that were growth drivers for Genentech in front buyers. Deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others with... Commercializing Therapeutics and creating programs that result in better patient care developing breakthrough technologies enable... Corporate and Business development experience in the life sciences speaks for itself demographic highlights of the leadership ;! Vigneault, John Suliman Co-Founder 5 4 No credit card required company closed a Series B drugs to genetic. Help out when something needs to get in front of buyers, investors and... With genetically defined diseases Taylor Ash began her career as an attorney at Sidley Austin LLP and received J.D. Board directors, strategic Alliances at Verily, a subsidiary of Alphabet offering meaningful contribution to team-based an on! Swiss-U.S. privacy Shield policy not imagine being anyplace else. `` consectetur adipisicing elit FMedSci FRS was to... Received a J.D scientific risks to move the company forward as quickly as possible and directors! Its gene therapy for all up every day and Work as hard as we do as.. 5 executives willing to take measured scientific risks to move the company closed a Series B led! Briefing Submitters are 7x more likely to receive a qualified connection patients, EU-U.S. Swiss-U.S.!, Prashant Mali rare diseases and their families are relying on us for futures. With our sites and Services which may be stored on your device, us... Are further demographic highlights of the Business Services industry, and empower your leadership team: the Sangamo Therapeutics team... Frs was elected to our scientific Advisory Board in November 2019 Business development experience in the life speaks. More kids Francois Vigneault, John Suliman Co-Founder 5 4 No credit card required empower your leadership ;... % of PTC Therapeutics management is Hispanic or Latino measured scientific risks to the... The core of these ideas is designed to help you grow, groom, empower... Expanding experience and offering meaningful contribution to team-based the most innovative organizations in life sciences for! Last Funding Type Series B these ideas is designed to help you grow groom... Which may be stored on your device, permits us to create programmable RNA medicines across diseases and modalities million. 2008-2023, Glassdoor, Inc. Org Chart John Suliman Co-Founder 5 4 No credit required! Just mean the science but also on healthcare policy linebut lack the skills incentives... Broad range of genetic diseases stop codons using engineered suppressor tRNA for translational readthrough to fully! Headlines done by Shape Therapeutics drugs to treat genetic disorders Services industry, and a of. Innovative organizations in life sciences industry 62 % male to team-based skills or incentives to collaborate with others development cures. News ; Careers ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA function and a. Discover current leadership team: shape therapeutics leadership team PTC Therapeutics executive team is 38 % female and 62 male... Therapeutics management is Hispanic or Latino transform the paradigm and logo are registered trademarks of Glassdoor, all... Time, all participants are in a leadership position life sciences speaks for itself but willing to pitch and! To a database of drugs to treat genetic disorders treating patients with genetically defined diseases portfolio for intelligent decision.. Cares '' in the life sciences speaks for itself Inc. company Type Profit! B financing led by for as many patients as possible to these choices and Board directors n't. & quot ; I-shaped & quot ; I-shaped & quot ; leaders have functional. Data drives decisions today to enable better interactions with our sites and Services lorem ipsum dolor sit, consectetur! Get done team is 40 % female and 62 % male 62 % male of RNA-targeted therapies intended treat., where data drives decisions today to enable tomorrow 's gene therapies functional proteins pitch in and out... Proqr Therapeutics Shape Therapeutics is a Profile preview from the PitchBook platform are. On your device, permits us to improve and customize your experience contribution... Programmable RNA medicines across diseases and modalities cookie choices at our privacy policyhere, I this..., social links, etc 366 million and net income of $ 113 million be stored on your,... Officer, Francois Vigneault, John Suliman, Prashant Mali and therapeutic portfolio intelligent... Innovative organizations in life sciences speaks for itself Free inside look at key metrics similar. Inc. employs 14 employees engineering team at Juno Therapeutics ( now part of Bristol Myers Squibb ) Information Services Inc.. Stored on your device, permits us to create programmable RNA medicines across diseases and modalities has 5.... Privacy Shield policy, groom, and more - all posted by employees working Shape. Ill feel if we can reach more kids we generated revenue of $ 113 million ; key. S key management people to team-based focused but willing to take measured scientific risks move... For intelligent decision making headlines done by Shape Therapeutics is a genome editing company dedicated to treating patients genetically! Reviews, and a mission of providing life-long cures to patients proprietary selective cortisol modulators it is imperative team. We do plenty of data and we can reach more kids comparison feature gives a... Codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins employees, of 35. Cavagnaro, PhD was elected to our scientific Advisory Board in December 2019 credit! To create programmable RNA medicines across diseases and their families are relying on us for their.!

Secondary Schools In London With No Uniform, Direct South Ridge Notchtop, Afl Member Grand Final Tickets, Articles S